Username

Password

Preview

Sign-in free and Explore the Exciting World of BiomedExperts:

Over 1.500.000 Profiles
More than 1.800 Organizations worldwide
State of the Art Network Visualizations

Manage your own Profile
Locate Experts in your Country/Region
Locate Experts in your 1. and 2. Level Network
Connect to Experts Worldwide

NetworkView

Matti Eskelinen

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Disorders

Phenomena

Mitotic Index

Chemicals & Drugs

Concepts & Ideas

Anatomy

Cell Nucleus

Procedures

Sign-in to see full Profile

Sign-in to see all Coauthors

Publications

TOP 3
Lintula Hannu; Kokki Hannu; Kettunen Riikka; Eskelinen Matti
Appendicitis score for children with suspected appendicitis. A randomized clinical trial.
Fagerholm Rainer; Hofstetter Barbara; Tommiska Johanna; Aaltonen Kirsimari; Vrtel Radek; Syrjäkoski Kirsi; Kallioniemi Anne; Kilpivaara Outi; Mannermaa Arto; Kosma Veli-Matti; Uusitupa Matti; Eskelinen Matti; Kataja Vesa; Aittomäki Kristiina; von Smitten Karl; Heikkilä Päivi; Lukas Jiri; Holli Kaija; Bartkova Jirina; Blomqvist Carl; Bartek Jiri; Nevanlinna Heli
NAD(P)H:quinone oxidoreductase 1 NQO1*2 genotype (P187S) is a strong prognostic and predictive factor in breast cancer.
Lintula Hannu; Kokki Hannu; Eskelinen Matti; Vanamo Kari
Laparoscopic versus open orchidopexy in children with intra-abdominal testes.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Matti Eskelinen (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Lintula Hannu; Kokki Hannu; Kettunen Riikka; Eskelinen Matti
Appendicitis score for children with suspected appendicitis. A randomized clinical trial.
Langenbeck's archives of surgery / Deutsche Gesellschaft für Chirurgie 2009;394(6):999-1004.
2008: Fagerholm Rainer; Hofstetter Barbara; Tommiska Johanna; Aaltonen Kirsimari; Vrtel Radek; Syrjäkoski Kirsi; Kallioniemi Anne; Kilpivaara Outi; Mannermaa Arto; Kosma Veli-Matti; Uusitupa Matti; Eskelinen Matti; Kataja Vesa; Aittomäki Kristiina; von Smitten Karl; Heikkilä Päivi; Lukas Jiri; Holli Kaija; Bartkova Jirina; Blomqvist Carl; Bartek Jiri; Nevanlinna Heli
NAD(P)H:quinone oxidoreductase 1 NQO1*2 genotype (P187S) is a strong prognostic and predictive factor in breast cancer.
Nature genetics 2008;40(7):844-53.
2008: Lintula Hannu; Kokki Hannu; Eskelinen Matti; Vanamo Kari
Laparoscopic versus open orchidopexy in children with intra-abdominal testes.
Journal of laparoendoscopic & advanced surgical techniques. Part A 2008;18(3):449-56.
2007: Harju Jukka; Pääkkönen Matti; Eskelinen Matti
Comparison of the quality of life after minilaparotomy cholecystectomy versus laparoscopic cholecystectomy: a prospective randomized study.
The Israel Medical Association journal : IMAJ 2007;9(3):147-8.
2007: Mäkinen Kimmo; Loimas Sami; Hakala Tapio; Eskelinen Matti
Tumour suppressor protein (p53), apoptosis inhibiting protein (Bcl-2) and proliferating cell nuclear antigen (PCNA) expressions in a rat pancreatic tumour model.
Anticancer research 2007;27(1A):23-6.
2007: Harju J; Pääkkönen M; Eskelinen M
Minilaparotomy cholecystectomy as a day surgery procedure: a prospective clinical pilot study.
Scandinavian journal of surgery : SJS : official organ for the Finnish Surgical Society and the Scandinavian Surgical Society 2007;96(3):206-8.
2006: Harju J; Juvonen P; Eskelinen M; Miettinen P; Pääkkönen M
Minilaparotomy cholecystectomy versus laparoscopic cholecystectomy: a randomized study with special reference to obesity.
Surgical endoscopy 2006;20(4):583-6.
2006: Hartikainen Jaana M; Tuhkanen Hanna; Kataja Vesa; Eskelinen Matti; Uusitupa Matti; Kosma Veli-Matti; Mannermaa Arto
Refinement of the 22q12-q13 breast cancer--associated region: evidence of TMPRSS6 as a candidate gene in an eastern Finnish population.
Clinical cancer research : an official journal of the American Association for Cancer Research 2006;12(5):1454-62.
2005: Kokki Hannu; Lintula Hannu; Vanamo Kari; Heiskanen Marjut; Eskelinen Matti
Oxycodone vs placebo in children with undifferentiated abdominal pain: a randomized, double-blind clinical trial of the effect of analgesia on diagnostic accuracy.
Archives of pediatrics & adolescent medicine 2005;159(4):320-5.
2005: Lintula Hannu; Pesonen Erkki; Kokki Hannu; Vanamo Kari; Eskelinen Matti
A diagnostic score for children with suspected appendicitis.
Langenbeck's archives of surgery / Deutsche Gesellschaft für Chirurgie 2005;390(2):164-70.
2005: Hartikainen Jaana M; Tuhkanen Hanna; Kataja Vesa; Dunning Alison M; Antoniou Antonis; Smith Paula; Arffman Airi; Pirskanen Mia; Easton Douglas F; Eskelinen Matti; Uusitupa Matti; Kosma Veli-Matti; Mannermaa Arto
An autosome-wide scan for linkage disequilibrium-based association in sporadic breast cancer cases in eastern Finland: three candidate regions found.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2005;14(1):75-80.
2004: Pellikainen Johanna M; Ropponen Kirsi M; Kataja Vesa V; Kellokoski Jari K; Eskelinen Matti J; Kosma Veli-Matti
Expression of matrix metalloproteinase (MMP)-2 and MMP-9 in breast cancer with a special reference to activator protein-2, HER2, and prognosis.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(22):7621-8.
2004: Pellikainen J; Naukkarinen A; Ropponen K; Rummukainen J; Kataja V; Kellokoski J; Eskelinen M; Kosma V-M
Expression of HER2 and its association with AP-2 in breast cancer.
European journal of cancer (Oxford, England : 1990) 2004;40(10):1485-95.
2004: Lintula Hannu; Kokki Hannu; Vanamo Kari; Valtonen Hannu; Mattila Matti; Eskelinen Matti
The costs and effects of laparoscopic appendectomy in children.
Archives of pediatrics & adolescent medicine 2004;158(1):34-7.
2004: Mustonen P K; Härmä M A; Eskelinen M J
The effect of fibrin sealant combined with fibrinolysis inhibitor on reducing the amount of lymphatic leakage after axillary evacuation in breast cancer. A prospective randomized clinical trial.
Scandinavian journal of surgery : SJS : official organ for the Finnish Surgical Society and the Scandinavian Surgical Society 2004;93(3):209-12.
2003: Julkunen Kristiina; Mäkinen Kimmo; Kärjä Vesa; Kosma Veli-Matti; Eskelinen Matti
alpha-, beta- and chi-catenin expression in human pancreatic cancer.
Anticancer research 2003;23(6D):5043-7.
2003: Enholm Susa; Hienonen Tuija; Suomalainen Anu; Lipton Lara; Tomlinson Ian; Kärjä Vesa; Eskelinen Matti; Mecklin Jukka-Pekka; Karhu Auli; Järvinen Heikki J; Aaltonen Lauri A
Proportion and phenotype of MYH-associated colorectal neoplasia in a population-based series of Finnish colorectal cancer patients.
The American journal of pathology 2003;163(3):827-32.
2003: Romppanen Jarkko; Romppanen Eeva-Liisa; Halonen Toivo; Eskelinen Matti; Punnonen Kari
Reference values of serum total sialic acid for healthy adult subjects and comparison of two different calibrators for quantitation of total sialic acid in high performance anion-exchange chromatography with pulsed amperometric detection.
Clinical chemistry and laboratory medicine : CCLM / FESCC 2003;41(8):1095-6.
2003: Pellikainen M J; Pekola T T; Ropponen K M; Kataja V V; Kellokoski J K; Eskelinen M J; Kosma V-M
p21WAF1 expression in invasive breast cancer and its association with p53, AP-2, cell proliferation, and prognosis.
Journal of clinical pathology 2003;56(3):214-20.
2002: Pellikainen Johanna; Kataja Vesa; Ropponen Kirsi; Kellokoski Jari; Pietiläinen Timo; Böhm Jan; Eskelinen Matti; Kosma Veli-Matti
Reduced nuclear expression of transcription factor AP-2 associates with aggressive breast cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2002;8(11):3487-95.
2002: Lintula Hannu; Kokki Hannu; Vanamo Kari; Antila Pentti; Eskelinen Matti
Laparoscopy in children with complicated appendicitis.
Journal of pediatric surgery 2002;37(9):1317-20.
2002: Böhm Jan; Niskanen Leo; Tammi Raija; Tammi Markku; Eskelinen Matti; Pirinen Risto; Hollmen Sinikka; Alhava Esko; Kosma Veli-Matti
Hyaluronan expression in differentiated thyroid carcinoma.
The Journal of pathology 2002;196(2):180-5.
2001: Ropponen K M; Kellokoski J K; Pirinen R T; Moisio K I; Eskelinen M J; Alhava E M; Kosma V M
Expression of transcription factor AP-2 in colorectal adenomas and adenocarcinomas; comparison of immunohistochemistry and in situ hybridisation.
Journal of clinical pathology 2001;54(7):533-8.
2001: Setälä L; Lipponen P; Tammi R; Tammi M; Eskelinen M; Alhava E; Kosma V M
Expression of CD44 and its variant isoform v3 has no prognostic value in gastric cancer.
Histopathology 2001;38(1):13-20.
2000: Böhm J; Niskanen L; Kiraly K; Kellokoski J; Eskelinen M; Hollmen S; Alhava E; Kosma V M
Expression and prognostic value of alpha-, beta-, and gamma-catenins indifferentiated thyroid carcinoma.
The Journal of clinical endocrinology and metabolism 2000;85(12):4806-11.
2000: Ropponen K M; Kellokoski J K; Lipponen P K; Eskelinen M J; Alanne L; Alhava E M; Kosma V M
Expression of inducible nitric oxide synthase in colorectal cancer and its association with prognosis.
Scandinavian journal of gastroenterology 2000;35(11):1204-11.
2000: Böhm J P; Niskanen L K; Pirinen R T; Kiraly K; Kellokoski J K; Moisio K I; Eskelinen M J; Tulla H E; Hollmen S; Alhava E M; Kosma V M
Reduced CD44 standard expression is associated with tumour recurrence and unfavourable outcome in differentiated thyroid carcinoma.
The Journal of pathology 2000;192(3):321-7.
2000: Karjalainen J M; Tammi R H; Tammi M I; Eskelinen M J; Agren U M; Parkkinen J J; Alhava E M; Kosma V M
Reduced level of CD44 and hyaluronan associated with unfavorable prognosis in clinical stage I cutaneous melanoma.
The American journal of pathology 2000;157(3):957-65.
2000: Karjalainen J M; Kellokoski J K; Mannermaa A J; Kujala H E; Moisio K I; Mitchell P J; Eskelinen M J; Alhava E M; Kosma V M
Failure in post-transcriptional processing is a possible inactivation mechanism of AP-2alpha in cutaneous melanoma.
British journal of cancer 2000;82(12):2015-21.
2000: Salovaara R; Loukola A; Kristo P; Kääriäinen H; Ahtola H; Eskelinen M; Härkönen N; Julkunen R; Kangas E; Ojala S; Tulikoura J; Valkamo E; Järvinen H; Mecklin J P; Aaltonen L A; de la Chapelle A
Population-based molecular detection of hereditary nonpolyposis colorectal cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2000;18(11):2193-200.
2000: Mäkinen K; Loimas S; Nuutinen P; Eskelinen M; Alhava E
The growth pattern and microvasculature of pancreatic tumours induced with cultured carcinoma cells.
British journal of cancer 2000;82(4):900-4.
2000: Auvinen P; Tammi R; Parkkinen J; Tammi M; Agren U; Johansson R; Hirvikoski P; Eskelinen M; Kosma V M
Hyaluronan in peritumoral stroma and malignant cells associates with breast cancer spreading and predicts survival.
The American journal of pathology 2000;156(2):529-36.
1999: Loukola A; Salovaara R; Kristo P; Moisio A L; Kääriäinen H; Ahtola H; Eskelinen M; Härkönen N; Julkunen R; Kangas E; Ojala S; Tulikoura J; Valkamo E; Järvinen H; Mecklin J P; de la Chapelle A; Aaltonen L A
Microsatellite instability in adenomas as a marker for hereditary nonpolyposis colorectal cancer.
The American journal of pathology 1999;155(6):1849-53.
1999: Böhm J; Kosma V M; Eskelinen M; Hollmen S; Niskanen M; Tulla H; Alhava E; Niskanen L
Non-suppressed thyrotropin and elevated thyroglobulin are independent predictors of recurrence in differentiated thyroid carcinoma.
European journal of endocrinology / European Federation of Endocrine Societies 1999;141(5):460-7.
1999: Keskikuru R; Kataja V; Kosma V M; Eskelinen M; Uusitupa M; Johansson R; Risteli L; Risteli J; Jukkola A
Preoperative high type I collagen degradation marker ICTP reflects advanced breast cancer.
Anticancer research 1999;19(5C):4481-4.
1999: Ropponen K M; Kellokoski J K; Lipponen P K; Pietiläinen T; Eskelinen M J; Alhava E M; Kosma V M
p22/WAF1 expression in human colorectal carcinoma: association with p53, transcription factor AP-2 and prognosis.
British journal of cancer 1999;81(1):133-40.
1999: Aaltomaa S; Lipponen P; Ala-Opas M; Eskelinen M; Syrjänen K; Kosma V M
Expression of cyclins A and D and p21(waf1/cip1) proteins in renal cell cancer and their relation to clinicopathological variables and patient survival.
British journal of cancer 1999;80(12):2001-7.
1999: Eskelinen M; Kataja V; Hämäläinen E; Kosma V M
Receiver-operating characteristic (ROC) curve analysis of cathepsin D and pS2 in breast disease; results from a prospective study.
Anticancer research 1999;19(4C):3463-7.
1999: Aaltomaa S; Lipponen P; Ala-Opas M; Eskelinen M; Kosma V M
Alpha-catenin expression has prognostic value in local and locally advanced prostate cancer.
British journal of cancer 1999;80(3-4):477-82.
1999: Aaltomaa S; Lipponen P; Eskelinen M; Ala-Opas M; Kosma V M
Prognostic value and expression of p21(waf1/cip1) protein in prostate cancer.
The Prostate 1999;39(1):8-15.
1999: Romppanen J; Keskikuru R; Kataja V; Eskelinen M; Kosma V M; Savolainen K; Uusitupa M; Mononen I
Measurement of prostate-specific antigen in detection of benign or malignant breast disease in women.
British journal of cancer 1999;79(9-10):1583-7.
1999: Setälä L P; Tammi M I; Tammi R H; Eskelinen M J; Lipponen P K; Agren U M; Parkkinen J; Alhava E M; Kosma V M
Hyaluronan expression in gastric cancer cells is associated with local and nodal spread and reduced survival rate.
British journal of cancer 1999;79(7-8):1133-8.
1999: Karjalainen J M; Eskelinen M J; Kellokoski J K; Reinikainen M; Alhava E M; Kosma V M
p21(WAF1/CIP1) expression in stage I cutaneous malignant melanoma: its relationship with p53, cell proliferation and survival.
British journal of cancer 1999;79(5-6):895-902.
1999: Aaltomaa S; Eskelinen M; Lipponen P
Expression of cyclin A and D proteins in prostate cancer and their relation to clinopathological variables and patient survival.
The Prostate 1999;38(3):175-82.
1999: Ropponen K M; Eskelinen M J; Lipponen P K; Alhava E M; Kosma V M
Reduced expression of alpha catenin is associated with poor prognosis in colorectal carcinoma.
Journal of clinical pathology 1999;52(1):10-6.
1998: Karjalainen J M; Kellokoski J K; Eskelinen M J; Alhava E M; Kosma V M
Downregulation of transcription factor AP-2 predicts poor survival in stage I cutaneous malignant melanoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1998;16(11):3584-91.
1998: Lipponen P; Aaltoma S; Kosma V M; Ala-Opas M; Eskelinen M
Expression of CD44 standard and variant-v6 proteins in transitional cell bladder tumours and their relation to prognosis during a long-term follow-up.
The Journal of pathology 1998;186(2):157-64.
1998: Lipponen P; Aaltomaa S; Eskelinen M; Ala-Opas M; Kosma V M
Expression of p21(waf1/cip1) protein in transitional cell bladder tumours and its prognostic value.
European urology 1998;34(3):237-43.
1998: Pesonen E; Eskelinen M; Juhola M
Treatment of missing data values in a neural network based decision support system for acute abdominal pain.
Artificial intelligence in medicine 1998;13(3):139-46.
1998: Karjalainen J M; Eskelinen M J; Nordling S; Lipponen P K; Alhava E M; Kosma V M
Mitotic rate and S-phase fraction as prognostic factors in stage I cutaneous malignant melanoma.
British journal of cancer 1998;77(11):1917-25.
1998: Aaltonen L A; Salovaara R; Kristo P; Canzian F; Hemminki A; Peltomäki P; Chadwick R B; Kääriäinen H; Eskelinen M; Järvinen H; Mecklin J P; de la Chapelle A
Incidence of hereditary nonpolyposis colorectal cancer and the feasibility of molecular screening for the disease.
The New England journal of medicine 1998;338(21):1481-7.
1998: Ropponen K M; Eskelinen M J; Lipponen P K; Alhava E; Kosma V M
Expression of CD44 and variant proteins in human colorectal cancer and its relevance for prognosis.
Scandinavian journal of gastroenterology 1998;33(3):301-9.
1998: Mäkinen K; Hakala T; Lipponen P; Alhava E; Eskelinen M
Clinical contribution of bcl-2, p53 and Ki-67 proteins in pancreatic ductal adenocarcinoma.
Anticancer research 1998;18(1B):615-8.
1998: Pesonen E; Ohmann C; Eskelinen M; Juhola M
Diagnosis of acute appendicitis in two databases. Evaluation of different neighborhoods with an LVQ neural network.
Methods of information in medicine 1998;37(1):59-63.
1998: Ropponen K; Tammi M; Parkkinen J; Eskelinen M; Tammi R; Lipponen P; Agren U; Alhava E; Kosma V M
Tumor cell-associated hyaluronan as an unfavorable prognostic factor in colorectal cancer.
Cancer research 1998;58(2):342-7.
1998: Setälä L; Kosma V M; Lipponen P; Naukkarinen A; Nordling S; Hollmén S; Eskelinen M; Syrjänen K; Alhava E
Clinical relevance of p53 index and expression of proliferating cell nuclear antigen and Ki-67 in gastric cancer.
Journal of cancer research and clinical oncology 1998;124(9):497-502.
1997: Setälä L P; Nordling S; Kosma V M; Lipponen P K; Eskelinen M J; Hollmén S M; Syrjänen K J; Alhava E M
Comparison of DNA ploidy and S-phase fraction with prognostic factors in gastric cancer.
Analytical and quantitative cytology and histology / the International Academy of Cytology [and] American Society of Cytology 1997;19(6):524-32.
1997: Auvinen P K; Parkkinen J J; Johansson R T; Agren U M; Tammi R H; Eskelinen M J; Kosma V M
Expression of hyaluronan in benign and malignant breast lesions.
International journal of cancer. Journal international du cancer 1997;74(5):477-81.
1997: Ropponen K M; Eskelinen M J; Lipponen P K; Alhava E; Kosma V M
Prognostic value of tumour-infiltrating lymphocytes (TILs) in colorectal cancer.
The Journal of pathology 1997;182(3):318-24.
1997: Romppanen J; Eskelinen M; Tikanoja S; Mononen I
Total and lipid-bound serum sialic acid in benign and malignant breast disease.
Anticancer research 1997;17(2B):1249-53.
1997: Setälä L; Lipponen P; Kosma V M; Marin S; Eskelinen M; Syrjänen K; Alhava E
Nuclear morphometry as a predictor of disease outcome in gastric cancer.
The Journal of pathology 1997;181(1):46-50.
1997: Aaltomaa S; Lipponen P; Vesalainen S; Ala-Opas M; Eskelinen M; Syrjänen K
Value of Ki-67 immunolabelling as a prognostic factor in prostate cancer.
European urology 1997;32(4):410-5.
1997: Aaltomaa S; Lipponen P; Ala-Opas M; Eskelinen M; Syrjänen K
Prognostic value of Ki-67 expression in renal cell carcinomas.
European urology 1997;31(3):350-5.
1996: Hakkarainen M; Wahlfors J; Myöhänen S; Hiltunen M O; Eskelinen M; Johansson R; Jänne J
Hypermethylation of calcitonin gene regulatory sequences in human breast cancer as revealed by genomic sequencing.
International journal of cancer. Journal international du cancer 1996;69(6):471-4.
1996: Ropponen K; Eskelinen M; Kosma V M; Lipponen P; Paakkinen P; Alhava E
Comparison of classic and quantitative prognostic factors in colorectal cancer.
Anticancer research 1996;16(6B):3875-82.
1996: Zhu Z; Parviainen M; Männistö S; Pietinen P; Eskelinen M; Syrjänen K; Uusitupa M
Vitamin E concentration in breast adipose tissue of breast cancer patients (Kuopio, Finland).
Cancer causes & control : CCC 1996;7(6):591-5.
1996: Setälä L P; Kosma V M; Marin S; Lipponen P K; Eskelinen M J; Syrjänen K J; Alhava E M
Prognostic factors in gastric cancer: the value of vascular invasion, mitotic rate and lymphoplasmacytic infiltration.
British journal of cancer 1996;74(5):766-72.
1996: Pesonen E; Eskelinen M; Juhola M
Comparison of different neural network algorithms in the diagnosis of acute appendicitis.
International journal of bio-medical computing 1996;40(3):227-33.
1996: Pietiläinen T; Lipponen P; Aaltomaa S; Eskelinen M; Kosma V M; Syrjänen K
The important prognostic value of Ki-67 expression as determined by image analysis in breast cancer.
Journal of cancer research and clinical oncology 1996;122(11):687-92.
1995: Pasanen P A; Eskelinen M; Partanen K; Pikkarainen P; Penttilä I; Alhava E
Multivariate analysis of six serum tumor markers (CEA, CA 50, CA 242, TPA, TPS, TATI) and conventional laboratory tests in the diagnosis of hepatopancreatobiliary malignancy.
Anticancer research 1995;15(6B):2731-7.
1995: Pietiläinen T; Lipponen P; Aaltomaa S; Eskelinen M; Kosma V M; Syrjänen K
Expression of p53 protein has no independent prognostic value in breast cancer.
The Journal of pathology 1995;177(3):225-32.
1995: Eskelinen M; Pasanen P; Janatuinen E; Pettersson N; Linnane A; Alhava E
Small intestinal mucin antigen (SIMA); a novel tumour marker in colorectal cancer?
Anticancer research 1995;15(5B):2351-6.
1995: Eskelinen M; Lipponen P; Nordling S
Prognostic evaluation of DNA flow cytometry and histo-morphological criteria in renal cell carcinoma.
Anticancer research 1995;15(5B):2279-83.
1995: Lipponen P; Pietiläinen T; Kosma V M; Aaltomaa S; Eskelinen M; Syrjänen K
Apoptosis suppressing protein bcl-2 is expressed in well-differentiated breast carcinomas with favourable prognosis.
The Journal of pathology 1995;177(1):49-55.
1995: Mäkinen K; Eskelinen M; Lipponen P; Alhava E
Expression of C-242 antigen in pancreatic ductal adenocarcinoma.
Anticancer research 1995;15(4):1605-8.
1995: Zhu Z R; Parviainen M; Männistö S; Pietinen P; Eskelinen M; Syrjänen K; Uusitupa M
Vitamin A concentration in breast adipose tissue of breast cancer patients.
Anticancer research 1995;15(4):1593-6.
1995: Pietiläinen T; Lipponen P; Aaltomaa S; Eskelinen M; Kosma V M; Syrjänen K
Expression of c-myc proteins in breast cancer as related to established prognostic factors and survival.
Anticancer research 1995;15(3):959-64.
1995: Lipponen P; Eskelinen M; Syrjänen K
Expression of tumour-suppressor gene Rb, apoptosis-suppressing protein Bcl-2 and c-Myc have no independent prognostic value in renal adenocarcinoma.
British journal of cancer 1995;71(4):863-7.
1995: Pasanen P; Eskelinen M; Kulju A; Penttilä I; Janatuinen E; Alhava E
Tumour-associated trypsin inhibitor (TATI) in patients with colorectal cancer: a comparison with CEA, CA 50 and CA 242.
Scandinavian journal of clinical and laboratory investigation 1995;55(2):119-24.
1995: Zhu Z R; Agren J; Männistö S; Pietinen P; Eskelinen M; Syrjänen K; Uusitupa M
Fatty acid composition of breast adipose tissue in breast cancer patients and in patients with benign breast disease.
Nutrition and cancer 1995;24(2):151-60.
1995: Pietiläinen T; Lipponen P; Aaltomaa S; Eskelinen M; Kosma V M; Syrjänen K
Expression of retinoblastoma gene protein (Rb) in breast cancer as related to established prognostic factors and survival.
European journal of cancer (Oxford, England : 1990) 1995;31A(3):329-33.
1995: Lipponen P K; Eskelinen M J
Reduced expression of E-cadherin is related to invasive disease and frequent recurrence in bladder cancer.
Journal of cancer research and clinical oncology 1995;121(5):303-8.
1994: Mäkinen K; Eskelinen M; Lipponen P; Pasanen P; Nuutinen P; Alhava E
Argyrophilic nucleolar organizer regions may help the differential diagnostic distinction between chronic pancreatitis and pancreatic ductal adenocarcinoma.
Scandinavian journal of gastroenterology 1994;29(11):1029-33.
1994: Eskelinen M; Ikonen J; Lipponen P
Contributions of history-taking, physical examination, and computer assistance to diagnosis of acute small-bowel obstruction. A prospective study of 1333 patients with acute abdominal pain.
Scandinavian journal of gastroenterology 1994;29(8):715-21.
1994: Lipponen P K; Eskelinen M J
Expression of pS2 protein in transitional cell bladder tumours.
The Journal of pathology 1994;173(4):327-32.
1994: Lipponen P; Eskelinen M
Expression of epidermal growth factor receptor in bladder cancer as related to established prognostic factors, oncoprotein (c-erbB-2, p53) expression and long-term prognosis.
British journal of cancer 1994;69(6):1120-5.
1994: Mäkinen K; Nuutinen P; Eskelinen M; Kosma V M; Alhava E
Sapphire probe versus bare fiber in interstitial laser hyperthermia (ILH). An experimental study with Wistar rats.
Anticancer research 1994;14(3A):1023-6.
1994: Eskelinen M; Pasanen P; Kulju A; Janatuinen E; Miettinen P; Poikolainen E; Tarvainen R; Nuutinen P; Pääkkönen M; Alhava E
Clinical evaluation of serum tumour markers CEA, CA 50 and CA 242 in colorectal cancer.
Anticancer research 1994;14(3B):1427-32.
1994: Pesonen E; Ikonen J; Juhola M; Eskelinen M
Parameters for a knowledge base for acute appendicitis.
Methods of information in medicine 1994;33(2):220-6.
1994: Lipponen P; Eskelinen M; Hietala K; Syrjänen K; Gambetta R A
Expression of proliferating cell nuclear antigen (PC10), p53 protein and c-erbB-2 in renal adenocarcinoma.
International journal of cancer. Journal international du cancer 1994;57(2):275-80.
1994: Pasanen P A; Eskelinen M; Partanen K; Pikkarainen P; Penttilä I; Alhava E
A prospective study of serum tumour markers carcinoembryonic antigen, carbohydrate antigens 50 and 242, tissue polypeptide antigen and tissue polypeptide specific antigen in the diagnosis of pancreatic cancer with special reference to multivariate diagnostic score.
British journal of cancer 1994;69(3):562-5.
1994: Eskelinen M; Hippeläinen M; Kettunen J; Salmela E; Penttilä I; Alhava E
Clinical value of serum tumour markers TPA, TPS, TAG 12, CA 15-3 and MCA in breast cancer diagnosis; results from a prospective study.
Anticancer research 1994;14(2B):699-703.
1994: Pasanen P A; Eskelinen M; Partanen K; Pikkarainen P; Penttilä I; Alhava E
Tumour-associated trypsin inhibitor in the diagnosis of pancreatic carcinoma.
Journal of cancer research and clinical oncology 1994;120(8):494-7.
1994: Pasanen P A; Eskelinen M; Partanen K; Pikkarainen P; Penttilä I; Alhava E
Diagnostic value of tissue polypeptide specific antigen in patients with pancreatic carcinoma.
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 1994;15(1):52-60.
1993: Eskelinen M; Lipponen P; Hippeläinen M; Seveus L; Syrajänen K
Expression of tumour associated antigens 12H12, 2E11, 7A9, CEA and DF3 in human breast cancer.
Anticancer research 1993;13(6B):2399-406.
1993: Eskelinen M; Lipponen P; Aitto-Oja L; Hall O; Syrjänen K
The value of histoquantitative measurements in prognostic assessment of renal adenocarcinoma.
International journal of cancer. Journal international du cancer 1993;55(4):547-54.
1993: Lipponen P K; Eskelinen M J; Jauhiainen K; Terho R; Nordling S
Proliferation indices as independent prognostic factors in papillary Ta-T1 transitional cell bladder tumours.
British journal of urology 1993;72(4):451-7.
1993: Pasanen P A; Eskelinen M; Partanen K; Pikkarainen P; Penttila I
Clinical evaluation of tissue polypeptide antigen (TPA) in the diagnosis of pancreatic carcinoma.
Anticancer research 1993;13(5C):1883-7.
1993: Hippeläinen M; Eskelinen M; Lipponen P; Chang F; Syrjänen K
Mitotic activity index, volume corrected mitotic index and human papilloma-virus suggestive morphology are not prognostic factors in carcinoma of the oesophagus.
Anticancer research 1993;13(3):677-81.
1993: Pasanen P A; Kauppinen R; Eskelinen M; Partanen K; Pikkarainen P; Alhava E
The value of combined use of serum tumour markers and nuclear magnetic spectroscopy of plasma in the detection of pancreatic cancer among patients with jaundice or cholestasis: results from a prospective study.
Anticancer research 1993;13(3):763-8.
1993: Pasanen P A; Eskelinen M; Partanen K; Pikkarainen P; Penttilä I; Alhava E
Receiver operating characteristic (ROC) curve analysis of the tumour markers CEA, CA 50 and CA 242 in pancreatic cancer; results from a prospective study.
British journal of cancer 1993;67(4):852-5.
1993: Aaltomaa S; Lipponen P; Eskelinen M; Kosma V M; Marin S; Alhava E; Syrjänen K
Comparison of classic and quantitative prognostic factors in hormone receptor-positive and hormone receptor-negative female breast cancer.
American journal of surgery 1993;165(3):307-11.
1993: Lipponen P K; Eskelinen M J
Expression of C-50 antigen as a prognostic variable in transitional cell bladder tumours.
British journal of urology 1993;71(2):192-8.
1993: Mäkinen K; Eskelinen M; Lipponen P; Nuutinen P; Marin S; Alhava E
Ag-NORs related to flow cytometry, morphometry and prognosis in patients with pancreatic cancer.
Anticancer research 1993;13(1):157-60.
1993: Lipponen P K; Eskelinen M J; Jauhiainen K; Harju E; Terho R; Haapasalo H
Grading of superficial bladder cancer by quantitative mitotic frequency analysis.
The Journal of urology 1993;149(1):36-41.
1993: Lipponen P K; Nordling S; Eskelinen M J; Jauhiainen K; Terho R; Harju E
Flow cytometry in comparison with mitotic index in predicting disease outcome in transitional-cell bladder cancer.
International journal of cancer. Journal international du cancer 1993;53(1):42-7.
1993: Aaltomaa S; Lipponen P; Eskelinen M; Kosma V M; Marin S; Alhava E; Syrjänen K
Predictive value of a morphometric prognostic index in female breast cancer.
Oncology 1993;50(1):57-62.
1993: Lipponen P K; Eskelinen M J; Jauhiainen K; Harju E; Terho R; Haapasalo H
Prognostic factors in nodular transitional cell bladder tumours.
Scandinavian journal of urology and nephrology 1993;27(2):205-10.
1993: Pasanen P A; Kauppinen R; Eskelinen M J; Partanen K P; Pikkarainen P H; Alhava E M
Nuclear magnetic resonance spectroscopy of plasma to distinguish between malignant and benign diseases causing jaundice and cholestasis.
Journal of cancer research and clinical oncology 1993;119(10):622-6.
1993: Lipponen P; Eskelinen M; Hemmilä I
Expression of the tumour-associated antigen CA-242 in transitional cell bladder tumours: a comparison with CA-50.
European journal of cancer (Oxford, England : 1990) 1993;29A(14):1935-40.
1992: Pasanen P A; Eskelinen M; Partanen K; Pikkarainen P; Penttilä I; Alhava E
A prospective study of the value of imaging, serum markers and their combination in the diagnosis of pancreatic carcinoma in symptomatic patients.
Anticancer research 1992;12(6B):2309-14.
1992: Eskelinen M; Hippeläinen M; Salmela E; Paajanen H; Alhava E; Syrjänen K
A prospective study of tissue polypeptide specific antigen (TPS) in breast cancer diagnosis.
Anticancer research 1992;12(6B):2033-6.
1992: Eskelinen M; Lipponen P; Syrjänen K
Nucleolar organiser regions (AgNORs) related to histopathological characteristics and survival in prostatic adenocarcinoma.
Anticancer research 1992;12(5):1635-40.
1992: Lipponen P; Papinaho S; Eskelinen M; Klemi P J; Aaltomaa S; Kosma V M; Marin S; Syrjänen K
DNA ploidy, S-phase fraction and mitotic indices as prognostic predictors of female breast cancer.
Anticancer research 1992;12(5):1533-8.
1992: Karjalainen J; Eskelinen M; Kosma V M; Lipponen P; Tuominen L; Alhava E
Clinical, histological and quantitative prognostic factors in cutaneous malignant melanoma.
Anticancer research 1992;12(5):1507-11.
1992: Eskelinen M; Hippeläinen M; Carlsson L; Jonsson P; Alhava E
A decision support system for predicting a recurrence of breast cancer; a prospective study of serum tumour markers TAG 12, CA 15-3 and MCA.
Anticancer research 1992;12(5):1439-42.
1992: Pasanen P A; Eskelinen M; Partanen K; Pikkarainen P; Penttilä I; Alhava E
Clinical value of serum tumour markers CEA, CA 50 and CA 242 in the distinction between malignant versus benign diseases causing jaundice and cholestasis; results from a prospective study.
Anticancer research 1992;12(5):1687-93.
1992: Lipponen P; Aaltomaa S; Eskelinen M; Kosma V M; Marin S; Syrjänen K
The changing importance of prognostic factors in breast cancer during long-term follow-up.
International journal of cancer. Journal international du cancer 1992;51(5):698-702.
1992: Eskelinen M; Lipponen P; Aaltomaa S; Kosma V M; Syrjänen K; Alhava E
Breast cancer in young women: clinical, histological and morphometric prognostic factors.
Anticancer research 1992;12(4):1237-42.
1992: Lipponen P K; Eskelinen M J
Cell proliferation of transitional cell bladder tumours determined by PCNA/cyclin immunostaining and its prognostic value.
British journal of cancer 1992;66(1):171-6.
1992: Eskelinen M; Lipponen P; Papinaho S; Aaltomaa S; Kosma V M; Klemi P; Syrjänen K
DNA flow cytometry, nuclear morphometry, mitotic indices and steroid receptors as independent prognostic factors in female breast cancer.
International journal of cancer. Journal international du cancer 1992;51(4):555-61.
1992: Collan Y; Klemi P; Kallioniemi O P; Joensuu H; Nordling S; Eskelinen M
Significance of variation in DNA flow cytometric analyses from paraffin-embedded breast cancers. Evaluation of the grading efficiency of ploidy determination, DNA index, and S-phase fraction.
Pathology, research and practice 1992;188(4-5):581-6.
1992: Lipponen P; Eskelinen M; Papinaho S; Klemi P J; Aaltomaa S; Kosma V M; Marin S; Syrjänen K
Sex steroid receptors, S-phase fraction and DNA ploidy as determinants of the risk of relapse and death of female breast cancer.
Anticancer research 1992;12(3):677-82.
1992: Lipponen P K; Eskelinen M J; Jauhiainen K; Harju E; Terho R; Haapasalo H
Independent clinical, histological and quantitative prognostic factors in transitional-cell bladder tumours, with special reference to mitotic frequency.
International journal of cancer. Journal international du cancer 1992;51(3):396-403.
1992: Pasanen P A; Eskelinen M; Partanen K; Pikkarainen P; Penttilä I; Alhava E
Clinical evaluation of a new serum tumour marker CA 242 in pancreatic carcinoma.
British journal of cancer 1992;65(5):731-4.
1992: Lipponen P K; Eskelinen M J; Jauhiainen K; Terho R; Nordling S
Independent prognostic factors in T2/T3 transitional cell bladder tumours with special reference to histoquantitative methods.
Surgical oncology 1992;1(2):135-43.
1992: Aaltomaa S; Lipponen P; Papinaho S; Klemi P; Kosma V M; Marin S; Eskelinen M; Alhava E; Syrjänen K
Nuclear morphometry and DNA flow cytometry as prognostic factors in female breast cancer.
The European journal of surgery = Acta chirurgica 1992;158(3):135-41.
1992: Lipponen P K; Eskelinen M J
Cell proliferation of transitional cell bladder cancer determined by PCNA/cyclin immunostaining. A histopathological description.
Anticancer research 1992;12(2):577-83.
1992: Eskelinen M; Lipponen P; Syrjänen K
Expression of tumour markers CA50, CEA and TPA in female breast carcinoma as related to histopathological findings and survival.
Anticancer research 1992;12(1):91-5.
1992: Eskelinen M; Hippelainen M; Salmela E; Paajanen H; Carlsson L; Jonsson P; Alhava E
Comparison of tumour markers TAG 12 with CA 15-3 and MCA in breast cancer diagnosis.
Anticancer research 1992;12(1):39-42.
1992: Aaltomaa S; Lipponen P; Eskelinen M; Kosma V M; Marin S; Alhava E; Syrjänen K
Prediction of outcome after first recurrence of breast cancer.
The European journal of surgery = Acta chirurgica 1992;158(1):13-8.
1992: Eskelinen M; Lipponen P; Marin S; Haapasalo H; Mäkinen K; Puittinen J; Alhava E; Nordling S
DNA ploidy, S-phase fraction, and G2 fraction as prognostic determinants in human pancreatic cancer.
Scandinavian journal of gastroenterology 1992;27(1):39-43.
1992: Aaltomaa S; Lipponen P; Eskelinen M; Kosma V M; Marin S; Alhava E; Syrjänen K
Mitotic indexes as prognostic predictors in female breast cancer.
Journal of cancer research and clinical oncology 1992;118(1):75-81.
1992: Aaltomaa S; Lipponen P; Eskelinen M; Kosma V M; Marin S; Alhava E; Syrjänen K
Prognostic factors after 5 years follow-up in female breast cancer.
Oncology 1992;49(2):93-8.
1992: Lipponen P K; Eskelinen M J
Argyrophilic nucleolar organiser regions in transitional cell bladder tumours related to established prognostic factors, progression and independent prognostic value.
Oncology 1992;49(2):133-8.
1992: Aaltomaa S; Lipponen P; Eskelinen M; Kosma V M; Mari S; Alhava E; Syrjänen K
Histological assessment of the prognostic factors in female breast cancer.
Oncology 1992;49(1):1-8.
1992: Aaltomaa S; Lipponen P; Eskelinen M; Kosma V M; Marin S; Alhava E; Syrjänen K
Lymphocyte infiltrates as a prognostic variable in female breast cancer.
European journal of cancer (Oxford, England : 1990) 1992;28A(4-5):859-64.
1992: Lipponen P K; Eskelinen M J; Jauhiainen K; Harju E; Terho P; Haapasalo H
Prognostic factors in WHO grade 2 transitional-cell bladder cancer (TCC); a novel two-grade classification system for TCC based on mitotic index.
Journal of cancer research and clinical oncology 1992;118(8):615-20.
1992: Aaltomaa S; Lipponen P; Eskelinen M; Kosma V M; Marin S; Alhava E; Syrjänen K
Tumor size, nuclear morphometry, mitotic indices as prognostic factors in axillary-lymph-node-positive breast cancer.
European surgical research. Europäische chirurgische Forschung. Recherches chirurgicales européennes 1992;24(3):160-8.
1992: Aaltomaa S; Lipponen P; Eskelinen M
Demographic prognostic factors in breast cancer.
Acta oncologica (Stockholm, Sweden) 1992;31(6):635-40.
1992: Eskelinen M; Pasanen P; Kosma V M; Alhava E
Primary malignant schwannoma of the small bowel.
Annales chirurgiae et gynaecologiae 1992;81(3):326-8.
1992: Lipponen P K; Eskelinen M J; Jauhiainen K; Harju E; Terho R
Tumour infiltrating lymphocytes as an independent prognostic factor in transitional cell bladder cancer.
European journal of cancer (Oxford, England : 1990) 1992;29A(1):69-75.
1992: Lipponen P K; Eskelinen M J; Jauhiainen K; Harju E; Terho R; Haapasalo H
Prediction of superficial bladder cancer by nuclear image analysis.
European journal of cancer (Oxford, England : 1990) 1992;29A(1):61-5.
1992: Eskelinen M; Lipponen P
A review of prognostic factors in human pancreatic adenocarcinoma.
Cancer detection and prevention 1992;16(5-6):287-95.
1991: Aaltomaa S; Lipponen P; Eskelinen M; Kosma V M; Marin S; Alhava E; Syrjänen K
Prognostic scores combining clinical, histological and morphometric variables in assessment of the disease outcome in female breast cancer.
International journal of cancer. Journal international du cancer 1991;49(6):886-92.
1991: Lipponen P K; Eskelinen M J; Kiviranta J; Pesonen E
Prognosis of transitional cell bladder cancer: a multivariate prognostic score for improved prediction.
The Journal of urology 1991;146(6):1535-40.
1991: Aaltomaa S; Lipponen P; Eskelinen M; Kosma V M; Marin S; Alhava E; Syrjänen K
Hormone receptors as prognostic factors in female breast cancer.
Annals of medicine 1991;23(6):643-8.
1991: Lipponen P K; Eskelinen M J; Nordling S
Nucleolar organiser regions (AgNORs) as predictors in transitional cell bladder cancer.
British journal of cancer 1991;64(6):1139-44.
1991: Lipponen P K; Collan Y; Eskelinen M J
Volume corrected mitotic index (M/V index), mitotic activity index (MAI), and histological grading in breast cancer.
International surgery 1991;76(4):245-9.
1991: Aaltomaa S; Lipponen P; Eskelinen M; Kosma V M; Marin S; Alhava E; Syrjänen K
Hormone receptor status and mitotic activity as risk factors for recurrence and death in female breast carcinoma.
Anticancer research 1991;11(5):1701-6.
1991: Eskelinen M; Lipponen P; Syrjänen K
TAG 12 expression as a prognostic factor in female breast cancer.
Anticancer research 1991;11(5):1683-6.
1991: Tervahauta A; Eskelinen M; Syrjänen S; Lipponen P; Pajarinen P; Syrjänen K
Immunohistochemical demonstration of c-erb B-2 oncoprotein expression in female breast cancer and its prognostic significance.
Anticancer research 1991;11(5):1677-81.
1991: Lipponen P K; Eskelinen M J; Collan Y
Immunohistochemical staining of CA 50 antigen in human bladder cancer. Relation to histologic grade, clinical stage, and prognosis.
Urology 1991;38(2):163-9.
1991: Eskelinen M; Kosma V M; Vainio J
Mesenchymoma of the chest wall in children.
The Annals of thoracic surgery 1991;52(2):291-3.
1991: Aaltomaa S; Lipponen P; Eskelinen M; Kosma V M; Marin S; Alhava E; Syrjänen K
The significance of nuclear morphometric variables as prognostic predictors in breast cancer.
Anticancer research 1991;11(4):1663-9.
1991: Aaltomaa S; Lipponen P; Eskelinen M; Alhava E; Syrjänen K
Nuclear morphometry and mitotic indexes as prognostic factors in breast cancer.
The European journal of surgery = Acta chirurgica 1991;157(5):319-24.
1991: Eskelinen M; Lipponen P; Marin S; Haapasalo H; Mäkinen K; Ahtola H; Puittinen J; Nuutinen P; Alhava E
Prognostic factors in human pancreatic cancer, with special reference to quantitative histology.
Scandinavian journal of gastroenterology 1991;26(5):483-90.
1991: Lipponen P K; Eskelinen M J; Kiviranta J; Nordling S
Classic prognostic factors, flow cytometric data, nuclear morphometric variables and mitotic indexes as predictors in transitional cell bladder cancer.
Anticancer research 1991;11(2):911-6.
1991: Lipponen P K; Eskelinen M J
How to count mitoses in bladder cancer grading?
Anticancer research 1991;11(2):825-9.
1991: Eskelinen M; Hippeläinen M; Carlsson L; Jonsson P
Clinical evaluation of a new tumour marker TAG 12 in breast cancer.
Anticancer research 1991;11(2):805-8.
1991: Lipponen P K; Eskelinen M J
Nucleolar organiser regions (NORs) in bladder cancer; relation to histological grade, clinical stage and prognosis.
Anticancer research 1991;11(1):75-80.
1991: Eskelinen M; Lipponen P; Collan Y; Marin S; Alhava E; Nordling S
Relationship between DNA ploidy and survival in patients with exocrine pancreatic cancer.
Pancreas 1991;6(1):90-5.
1991: Lipponen P K; Eskelinen M J; Nordling S
Relationship between DNA flow cytometric data, nuclear morphometric variables and volume-corrected mitotic index in transitional cell bladder tumors.
European urology 1991;19(4):327-31.
1991: Eskelinen M; Lipponen P; Majapuro R; Syrjänen K
Prognostic factors in prostatic adenocarcinoma assessed by means of quantitative histology.
European urology 1991;19(4):274-8.
1991: Lipponen P K; Eskelinen M J; Sotarauta M
Prediction of T1-2 GI-II transitional cell bladder cancer; evaluation by histoquantitative methods.
Scandinavian journal of urology and nephrology 1991;25(2):129-34.
1991: Lipponen P K; Eskelinen M J; Nordling S
Progression and survival in transitional cell bladder cancer: a comparison of established prognostic factors, S-phase fraction and DNA ploidy.
European journal of cancer (Oxford, England : 1990) 1991;27(7):877-81.
1991: Eskelinen M J; Lipponen P K; Collan Y; Syrjänen K J
The role of nucleolar organiser regions as prognostic factors in breast cancer.
European journal of cancer (Oxford, England : 1990) 1991;27(8):989-92.
1991: Lipponen P K; Eskelinen M J; Nordling S
Intratumoral heterogeneity of DNA indexes in transitional cell bladder cancer: relation to tumor histology.
European urology 1991;20(4):311-4.
1991: Aaltomaa S; Lipponen P; Eskelinen M; Kosma V M; Marin S; Alhava E; Syrjänen K
Prognostic factors in axillary lymph node-negative (pN-) breast carcinomas.
European journal of cancer (Oxford, England : 1990) 1991;27(12):1555-9.
1991: Lipponen P; Eskelinen M; Syrjänen S; Tervahauta A; Syrjänen K
Use of immunohistochemically demonstrated c-erb B-2 oncoprotein expression as a prognostic factor in transitional cell carcinoma of the urinary bladder.
European urology 1991;20(3):238-42.
1990: Lipponen P; Eskelinen M
Nuclear morphometry in grading transitional cell bladder cancer compared with subjective histological grading.
Anticancer research 1990;10(6):1725-30.
1990: Eskelinen M; Collan Y; Pajarinen P; Pesonen E; Kettunen K; Nordling S
An improved prognostic index of axillary node involvement in breast cancer incorporating DNA ploidy and tumour size.
Acta chirurgica Scandinavica 1990;156(8):521-7.
1990: Eskelinen M; Tikanoja S; Brown J
Clinical evaluation of new serum tumor markers CA M26 and CA M29 in patients with primary breast cancer.
Anticancer research 1990;10(4):959-62.
1990: Lipponen P K; Collan Y; Eskelinen M J; Pesonen E; Sotarauta M; Nordling S
Comparison of morphometry and DNA flow cytometry with standard prognostic factors in bladder cancer.
British journal of urology 1990;65(6):589-97.
1990: Lipponen P K; Eskelinen M J; Collan Y; Marin S; Alhava E
Volume-corrected mitotic index in human pancreatic cancer. Relation to histologic grade, clinical stage, and prognosis.
Scandinavian journal of gastroenterology 1990;25(6):548-54.
1990: Eskelinen M; Lipponen P; Collan Y
Immunohistochemical staining of human breast cancer with a new tumour marker MCA: relation to axillary lymph node involvement, metastasis, and survival.
Anticancer research 1990;10(3):591-6.
1990: Eskelinen M; Vainio J; Tuominen L; Vihko R; Klemi P; Collan Y
Carcinoma of the breast in children.
Zeitschrift für Kinderchirurgie : organ der Deutschen, der Schweizerischen und der Osterreichischen Gesellschaft für Kinderchirurgie = Surgery in infancy and childhood 1990;45(1):52-5.
1990: Lipponen P K; Kosma V M; Collan Y; Kulju T; Kosunen O; Eskelinen M
Potential of nuclear morphometry and volume-corrected mitotic index in grading transitional cell carcinoma of the urinary bladder.
European urology 1990;17(4):333-7.
1990: Eskelinen M; Collán Y; Pesonen E; Salonen J T
Factors associated with risk of breast cancer and persistence of symptoms in women with breast problems.
Annales chirurgiae et gynaecologiae 1990;79(1):10-4.
1990: Lipponen P K; Collan Y; Eskelinen M J; Pesonen E; Sotarauta M
Volume corrected mitotic index (M/V index) in human bladder cancer; relation to histological grade (WHO), clinical stage (UICC) and prognosis.
Scandinavian journal of urology and nephrology 1990;24(1):39-45.
1990: Lipponen P K; Collan Y; Eskelinen M J; Pesonen E; Sotarauta M
Morphometry in human transitional cell bladder cancer. Nuclear area and standard deviation of nuclear area--relation to tumor grade (WHO) and prognosis.
European urology 1990;17(2):155-60.
1990: Lipponen P K; Eskelinen M J; Collan Y; Pesonen E; Ventilä T; Sotarauta M; Nordling S
DNA ploidy and S phase fraction in human bladder cancer. Relation to survival and histological grade (WHO).
Urologia internationalis 1990;45(1):4-9.
1990: Lipponen P K; Eskelinen M J
Volume-corrected mitotic index and mitotic activity index in transitional cell bladder cancer.
European urology 1990;18(4):258-62.
1990: Lipponen P K; Eskelinen M J; Collan Y
Prognostication of bladder carcinoma by immunohistochemistry: refined and combined analysis of staining for MCA and CA50.
Urologia internationalis 1990;45(6):361-6.
1990: Lipponen P K; Eskelinen M J; Sotarauta M
Prediction of superficial bladder cancer by histoquantitative methods.
European journal of cancer (Oxford, England : 1990) 1990;26(10):1060-3.
1989: Eskelinen M; Nordling S; Puittinen J; Pesonen E; Collan Y
The flow-cytometric analysis of DNA content and S-phase fraction (SPF) of human breast cancer.
Pathology, research and practice 1989;185(5):694-7.
1989: Lipponen P; Simpanen H; Pesonen E; Eskelinen M; Sotarauta M; Collan Y
Potential of morphometry in grading transitional cell carcinoma of the urinary bladder.
Pathology, research and practice 1989;185(5):617-20.
1989: Eskelinen M; Tikanoja S; Collan Y
Efficient test for cancer antigens: decreased levels of cancer antigen in serum after excision of breast tumor.
Anticancer research 1989;9(2):437-9.
1989: Eskelinen M; Collán Y; Puittinen J; Pajarinen P; Alhava E
Lymphoma of the breast.
Annales chirurgiae et gynaecologiae 1989;78(2):149-52.
1988: Eskelinen M; Tikanoja S; Collan Y
A new tumor marker MCA in breast cancer diagnosis.
Anticancer research 1988;8(4):665-8.

Sign-in to see more

Sign-in free and Explore the Exciting World of BiomedExperts:

NetworkView

Matti Eskelinen

Research Profile (preview)

Disorders

Phenomena

Chemicals & Drugs

Concepts & Ideas

Anatomy

Procedures

Network (preview)

Publications

Sign in free and see...

Visualized networks:

GeoTargeted Searches:

Research Profiles:

Geonetwork of Matti Eskelinen (preview)

All Publications